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Abstract  19 
 20 
Tetraspanins, such as CD81, can form lateral associations with each other and with other 21 
transmembrane proteins. These interactions may underlie CD81 functions in multiple cellular 22 
processes, such as adhesion, morphology, migration and differentiation. Since CD81 role in 23 
neuronal cells’ migration has not been established, we here evaluated CD81 effects in the 24 
migratory phenotype of SH-SY5Y neuroblastoma cells. CD81 was enriched at SHSY-5Y 25 
cell’s membrane, co-localizing with its interactor F-actin in migratory-relevant structures of 26 
the leading edge (filopodia, stress fibres and adhesion sites). CD81 overexpression increased 27 
the number of cells with a migratory phenotype, in a potentially PI3K-AKT mediated 28 
manner. Indeed, CD81 also co-localized with AKT, a CD81-interactor and actin remodel 29 
agent, at the inner leaflet of the plasma membrane. Pharmacologic inhibition of PI3K, the 30 
canonical AKT activator, led both to a decrease in the acquisition of a migratory phenotype 31 
and to a redistribution of intracellular CD81 and F-actin into cytoplasmic agglomerates. 32 
These findings suggest that in neuronal-like cells CD81 bridges active AKT and actin, 33 
promoting the actin remodelling that leads to a motile cell morphology. Further studies on 34 
this CD81-mediated mechanism will improve our knowledge on important physiological and 35 
pathological processes such as cell migration and differentiation, and tumour metastasis. 36 
 37 
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Introduction  41 
CD81 is a 26 kDa integral membrane protein member of the tetraspanin family, an 42 
evolutionarily conserved family of membrane proteins containing 4 transmembrane domains 43 
and expressed in most human tissues (Hemler 2005). Tetraspanins have the striking ability to 44 
form lateral associations with each other and with other tissue type-specific proteins, at the 45 
cell membrane. These associations take the form of tetraspanin-enriched microdomains 46 
(TEM) that form a dynamic membrane network known as the ‘tetraspanin web’ (Shoham et 47 
al. 2006). Tetraspanins regulate a wide range of proteins such as integrins, cell surface 48 
receptors, and signalling molecules (Jiang et al. 2015). A major difficulty in the study of 49 
tetraspanins is to identify functions that are specific for a given tetraspanin, and to determine 50 
how this function relates to specific tetraspanin-associated proteins (Boucheix et al. 2001).  51 
CD81 has been emerging as a regulator of a multitude of cellular processes, including 52 
adhesion, proliferation, differentiation, cell migration, and microvillus formation (Bari et al. 53 
2011; Levy et al. 1998). Cell migration is usually driven by extracellular signals and involves 54 
an assemblage of protein-protein interactions. The proteins that play a role in this process 55 
include cadherins (involved in cell-cell adhesion), integrins (involved in cell-extracellular 56 
matrix (ECM) adhesion), Rac/Rho (for actin cytoskeletal remodelling, 57 
protrusion/contraction), and matrix metalloproteinases (for pericellular proteolysis/proteolytic 58 
ECM remodelling) (Jiang et al. 2015). Increasing evidence indicates that the CD81 59 
tetraspanin may help to coordinate the cell migration process by regulating the function of 60 
key proteins involved in all aspects of this process. For example, CD81 supports maturation 61 
and surface expression of EWI-2, which modulates integrin-dependent cell motility and 62 
spreading. CD81 is also closely associated with the α4β1 integrin, regulating α4β1 adhesion 63 
under shear flow conditions. The association of CD81 with type II phosphatidylinositol 4-64 
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kinase (PI4K) is also believed to play a role in cell migration and tumour cell proliferation 65 
(Boucheix & Rubinstein 2001; Hemler 2005; Jiang et al. 2015). In immune cells, CD81 66 
regulates the dynamics and membrane localization of the small GTPase Rac1 during 67 
membrane protrusion, and promotes the formation of adhesion complexes (Tejera et al. 68 
2013).   69 
CD81 is mainly studied in the immune system, but a few studies have started to implicate 70 
CD81 in the nervous system physiology (Boucheix et al. 2001; Hemler et al. 2005). As 71 
various mechanisms of cell migration are similar in cells of various origins, a role for CD81 72 
in neuronal migration is plausible. Neuronal migration is, along with axon guidance, a 73 
fundamental and critical mechanism underlying the development of the brain architecture, 74 
and also in neuroregeneration. Migrating neurons are highly polarized in the direction of their 75 
movement and undergo the extension of a leading process, the translocation of the nucleus 76 
into the leading process, and the elimination of the migrating neuron’s trailing process, 77 
leading to the net movement of the cell (Marín et al. 2010). As all these involve actin 78 
remodelling and cell adhesion, we here evaluated, for the first time, if CD81 regulates actin 79 
remodelling and motility-related cell morphology in neuronal-like cells. 80 
81 
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Materials and Methods 82 
SH-SY5Y cell culture, transfection and pharmacologic modulation 83 
The SH-SY5Y human neuroblastoma cell line is one of the best well-established in vitro 84 
neuronal model (da Rocha et al. 2015). Undifferentiated SH-SY5Y cells are morphologically 85 
described as neuroblast-like, non-polarized cell bodies with few truncated processes 86 
(Kovalevich & Langford 2013). These characteristics make them a suitable model to study 87 
the effects of CD81 in the migratory phenotype of neuronal-like cells. SH-SY5Y cells were 88 
maintained in Minimum Essential Media (MEM):F12 (1:1) supplemented with 10% Fetal 89 
Bovine Serum (FBS; Gibco, Thermo Fisher) and 1% Antibiotic-Antimycotic solution (AA; 90 
Gibco, Thermo Fisher), in a 5% CO2 humidified incubator at 37oC. Cells were sub-cultured 91 
when a cell density of 90% was achieved, and plated on sterilized coverslips inside six-well 92 
plates. When indicated, SH-SY5Y cells were transfected for 24 h with 1 µg of pCDM8 93 
hCD81 cDNA (Addgene plasmid # 11588; a kind gift from Dr. Shoshana Levy) using the 94 
TurboFect™ reagent (Fermentas Life Science). For the inhibition of PI3K, CD81 transfected 95 
cells were treated with 10 µM of the phosphatidylinositol 3 kinase (PI3K) inhibitor 96 
LY294002 (Selleck Chemicals), for 18 hours before fixation.  97 
 98 
Immunocytochemistry (ICC) and microscopy  99 
Non-transfected and CD81 transfected SH-SY5Y cells were fixed with 4% paraformaldehyde 100 
and permeabilized with 0.2% Triton X-100 for 10 min. For immunocytochemistry (ICC) 101 
procedures, the following primary and secondary antibodies were incubated for 1-2h, 102 
following the manufacturer’s instructions: mouse monoclonal anti-CD81 M38 (Abcam, Cat. 103 
No. ab79559); rabbit monoclonal anti-AKT (Cell Signalling Cat. No. 9272) and Alexa 488- 104 
and 594-conjugated IgGs (Molecular Probes). To stain F-actin, Alexa Fluor Phalloidin in 1% 105 
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bovine serum albumin (BSA) phosphate-buffered saline (PBS) was added 30 min in the dark. 106 
After three washes with PBS and a last one with distilled water, preparations were mounted 107 
with Vectashield® media (Vector Laboratories) containing or not the DAPI nuclear staining 108 
probe. Fixed cells were visualized by confocal microscopy [LSM 510 Meta confocal 109 
microscope (Carl Zeiss), with a 63x oil objective].  110 
 111 
Cells morphological analysis  112 
The morphology of the transfected and non-transfected cells was monitored to score the 113 
typical migratory phenotype of spatial asymmetry with a clear distinction between cell front 114 
and rear, stress fibres along the cell, lamellipodia and filopodia at the cell front, and actin 115 
filament rearrangements (Qian et al. 2005). The migratory phenotype was monitored in ~65 116 
transfected and ~100 non-transfected cells, in five independent biological replicas (n=5). Cell 117 
count was performed using the ‘cell counter’ plugin of the ImageJ software (U.S. National 118 
Institute of Health), and data expressed as the percentage of cells with a migratory phenotype 119 
as a function of the total number of scored cells. In the PI3K inhibition assays, the decrease in 120 
the percentage of CD81 transfected migratory cells, resulting from the presence of the PI3K 121 
LY294002 inhibitor, was quantified in three independent biological replicas (n=3), where the 122 
migratory phenotype was monitored in 100-135 transfected cells per condition.  123 
 124 
Data analysis and statistics  125 
Data was expressed as mean values of at least triplicates,  standard error of the mean. 126 
Statistical analysis was performed using the Statistical Package for the Social Sciences 127 
(SPSS) software (version 19). The normality was tested with the Shapiro-Wilk test and all p 128 
values were > 0.05, so the null hypotheses that these data were sampled from normally 129 
distributed populations, were not rejected. Nevertheless, due to the small sample size, both 130 
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parametric and non-parametric tests were used for post hoc evaluations of differences among 131 
groups. The independent sample t-test and the Mann-Whitney U test were used for statistical 132 
significance analysis of the migratory phenotype data of Figure 1. The one-tail Student’s t-133 
test and the Wilcoxon test were used for statistical significance analysis of PI3K inhibition 134 
data (Figure 3). p < 0.05 in at least one of the tests was considered as statistically significant. 135 
136 
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Results 137 
 138 
CD81 co-localizes with F-actin in motile-related structures 139 
To be able to migrate, cells have to acquire a polarized migratory phenotype that involves the 140 
remodelling of its cytoskeleton, with particular emphasis on the actin cytoskeleton (Qian et 141 
al. 2005; Xue & Hemmings 2013). CD81 is known to physically interact with actin, and to 142 
promote cytoskeleton remodelling in other cell types (Perez-Hernandez et al. 2013; Tejera et 143 
al. 2013). In order to better understand the influence of CD81 in neuronal cytoskeleton 144 
remodelling, and to access its co-localization with actin in SH-SY5Y cells, an ICC analysis 145 
was performed in SH-SY5Y cells. Results show that CD81 was highly located at the cells’ 146 
membranes, including in structures also stained for filamentous actin (F-actin), when at 147 
endogenous levels (Figure 1A) but particularly when overexpressed (Figure 1B). Moreover, 148 
CD81 was particularly enriched in structures related to cell migration, such as filopodia 149 
(Figure 1B, open arrows in dashed rectangle), stress fibres (Figure 1B, full arrows, as in 150 
(Auer et al. 2017)) and stress fibres’ terminals, most likely adhesion sites (Figure 1B, 151 
asterisks). These are subcellular regions where a high degree of co-localization between F-152 
actin and transfected CD81 could be observed (Figure 1B, orange staining in ‘Merge’).  153 
 154 
CD81 overexpression promotes the acquisition of a migratory phenotype  155 
A first observation of the CD81 overexpressing neuroblastoma population denoted the 156 
presence of a high number of cells with a migratory phenotype. This includes a more 157 
triangular shape, F-actin concentration at the leading front and at the cell’s rear, and a typical 158 
array distribution of the stress fibres (Bari et al. 2011; Qian et al. 2005). The number of 159 
CD81 overexpressing cells with this phenotype was scored, and compared to the number of 160 
migratory-like non-transfected cells in the neighbourhood. Data shows that CD81 161 
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overexpression doubled the number of cells with this migratory phenotype (Figure 1C). 162 
These results suggest a role for CD81 in promoting cellular mechanisms that underlie the 163 
acquisition of a migratory phenotype. Further, they suggest that actin, a known interactor of 164 
CD81 (Perez-Hernandez et al. 2013), is involved in the CD81 effects on cell morphological 165 
transformation. 166 
 167 
CD81 co-localizes with AKT, in transfected and non-transfected SH-SY5Y cells 168 
We further analysed if another CD81 interactor, AKT, could also be involved in CD81-169 
promotion of neuronal-like cells migratory phenotype. AKT (also known as protein kinase B) 170 
is a serine/threonine protein kinase that regulates many processes, including metabolism, 171 
proliferation, cell survival, growth and angiogenesis (Yu & Cui 2016). When activated by 172 
PI3K, AKT phosphorylates various substrates involved in cytoskeleton remodelling, cell 173 
growth and cell survival in neurons. Moreover, the PI3K/AKT signalling pathway is essential 174 
for the modulation of the cytoskeleton during cell migration (Xue et al. 2013). As AKT is a 175 
CD81 interactor protein, and also the best-known target of PI3K, we investigated if the 176 
activation of the AKT/PI3K pathway is part of the mechanism by which CD81 promotes 177 
actin remodelling by blocking PI3K to prevent activation and phosphorylation of AKT. 178 
Co-localization analyses, both in CD81 transfected and non-transfected cells (Figure 2), 179 
showed that AKT1 was present in the cytosol and at the plasma membrane of the SH-SY5Y 180 
cells. Moreover, it could be observed that AKT1 mainly co-localized with CD81 at cellular 181 
projections (Figure 2B, open arrows) and at the inner leaflet of the plasma membrane (Figure 182 
2, full arrows). Scarcer co-localization between these proteins was observed in cytoplasmic 183 
zones further away from the PM. Since AKT is cytoplasmic and translocates to the plasma 184 
membrane when activated, this co-localization suggests that CD81 interacts particularly with 185 
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the active form of AKT, and that AKT signalling might be involved in CD81 functions in cell 186 
motility.  187 
 188 
PI3K/AKT signalling is involved in CD81-mediated actin remodelling and migratory 189 
phenotype  190 
PI3K is a canonical upstream activator of AKT, and a possible functional interaction between 191 
CD81 and the PI3K-AKT pathway was pursued by treating CD81 transfected cells with 192 
LY294002, a PI3K inhibitor. Inhibition of PI3K resulted in a ~40% decrease in the 193 
percentage of transfected cells with a migratory phenotype, when compared to non-treated 194 
control cells (Figure 3A). PI3K inhibition also inhibited the acquisition of a migratory 195 
phenotype in non-transfected cells, although only by ~20% (data not shown). These results 196 
strengthen the hypothesis that the PI3K-AKT pathway mediates the CD81 promotion of 197 
migration in these neuronal-like cells.  198 
Further, when treated with LY294002 (Figures 3B and 4), CD81 still strongly co-localized 199 
with F-actin in CD81 overexpressing cells as it did in unexposed cells of Figure 1B. 200 
Nevertheless, contrary to untreated cells where stress fibres and normal F-actin distribution is 201 
observed (Figure 1B), the F-actin distribution was now altered. CD81 overexpressing cells 202 
exposed to the PI3K inhibitor presented less stress fibres (Figures 3B and 4, arrowheads) and 203 
a redistribution of the CD81 staining pattern (Figures 3B and 4 open arrows). A more 204 
thorough analysis of the CD81 and F-actin distribution in SH-SY5Y cells exposed to the 205 
PI3K (Figure 4) revealed that CD81 overexpressing cells had a high number of CD81- and F-206 
actin positive filopodia (or less and longer filopodia), but very few stress fibres (arrowheads 207 
in Figures 3B and 4). Moreover, CD81 was less enriched at the cell periphery, and was 208 
redistributed from the cell membrane to the perinuclear region and to cytoplasmic 209 
agglomerates (Figure 4, arrowheads and zoom-in of the nuclear plane). The percentage of 210 
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CD81 transfected cells with a perinuclear ring-like enrichment triplicated when PI3K was 211 
inhibited  (from ~10% to ~30%), and the number of smaller differentiated cells, with 212 
filopodia and cortical F-actin but no stress fibres, duplicated (data not shown). Taken 213 
together, these results indicate that the PI3K/AKT signalling pathway is part of the CD81 214 
mechanism of F-actin remodelling into cell motility-related structures.  215 
216 
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Discussion 217 
 218 
CD81 is a tetraspanin protein that has been mainly studied in the immune system. Few 219 
functions have been attributed to it, but it has been implicated in processes such as cell 220 
adhesion and migration. Its expression levels, subcellular distribution and functions in other 221 
cells, such as neuronal cells, are still barely known. In the present work, we aimed to evaluate 222 
the role of CD81 in the migratory phenotype of these neuronal-like cells. 223 
We first confirmed that CD81 is endogenously expressed in the nervous system-related SH-224 
SY5Y cell line. This is not surprising since CD81 has been already implicated in the nervous 225 
system physiology, being required for the normal development of the brain (Geisert et al. 226 
2002). Geisert et al. (2002) studied the effects of a CD81 -/- mutation on the CNS of mice 227 
and reported that these mice have extremely large brains. This was as a result of an increased 228 
number of astrocytes and microglia, with no apparent effect on the number of neurons and 229 
oligodendrocytes (Geisert et al. 2002). Accordingly, CD81 was reported to control astrocytes 230 
and microglia cell number by suppressing cell proliferation, in a cell-cell contact-dependent 231 
manner (Kelić et al. 2001). Potentially related to this, CD81 is found concentrated at regions 232 
of cell-cell contact in cultured astrocytes, and may play a central role in the process of CNS 233 
scar formation in spinal cord injury (Dijkstra et al. 2000).  234 
In the work here presented we additionally observed that CD81 is mainly present at the 235 
plasma membrane of SH-SY5Y neuroblastoma cells, as expected for a protein of the 236 
tetraspanin family. CD81 was also found in some spot-like structures of the cytoplasm, with 237 
the smaller of these potentially being exosomes, since CD81 was recently observed to be 238 
enriched in exosomes-like vesicles (Andreu et al. 2014). 239 
More importantly, CD81 was found to clearly promote the number of migrating neuronal-like 240 
cells, similarly to its role in immune cells. Cell migration is a highly coordinated cellular 241 
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event, key for various physiological and pathological major processes, including embryonic 242 
development, wound healing, immune response (Qian et al 2004). Migration is highly based 243 
on actin filament polymerization and remodelling, and motile cells have characteristic 244 
discrete actin structures at the cell periphery for attachment to the substratum: focal adhesion, 245 
stress fibres, lamellipodia, filopodia, and membrane ruffles (Hall 1998). Overexpression of 246 
CD81 alone altered the cells morphology, inducing a reorganization of the actin filaments 247 
into cell motility-related structures. 248 
A previous bioinformatics analysis of CD81-interacting proteins performed by our group 249 
(unpublished data) showed that CD81 was linked to intracellular signalling components 250 
involved in cytoskeletal regulation. Included in this group were the following key proteins: 251 
AKT1, Rac and cytoskeleton-related proteins, including actin and tubulin. Actin itself is a 252 
CD81 interacting protein, as described by Perez-Hernandez et al. (2013). Our results 253 
demonstrated that CD81 perfectly co-localizes with F-actin in stress fibres and filopodia at 254 
the leading edge of migrating SH-SY5Y cells. We have also observed that CD81 is highly 255 
abundant in cytoplasmic cellular spots at the end of the stress fibres that transverse the cell, 256 
most probably mature focal adhesions. These are key subcellular locations for a protein with 257 
regulatory role on cell migration, and agree with such a role for CD81 on neuronal cells. The 258 
CD81 role in neuronal cell migration seems not only to involve F-actin, but also other actin 259 
regulators, such as AKT1. The AKT kinase plays a crucial role in neurogenesis by activating 260 
the proliferation, migration and differentiation of neural stem and other cells (Koh & Lo 261 
2015; Qian et al. 2005). AKT1 is an AKT isoform involved in a variety of signalling 262 
pathways related to cell motility and cytoskeleton remodelling. When AKT1 is activated by 263 
phosphorylation in the cytoplasm, it is targeted to the inner leaflet of the plasma membrane 264 
and phosphorylates a number of subtracts, including actin (Xue et al. 2013).  In the present 265 
work, we performed an ICC in SH-SY5Y cells to access the subcellular co-localization of 266 
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CD81 and AKT1. AKT1 presented the expected subcellular localization along the entire 267 
cytoplasm but, interestingly, CD81 and AKT1 mainly co-localized at the inner leaflet of the 268 
plasma membrane and at some cellular projections. In CD81 overexpressing migrating cells, 269 
AKT1 co-localized with CD81 at the leading edge. These suggest that CD81 co-localizes 270 
with active, membrane-recruited AKT1, and raises the hypothesis that a tri-complex of 271 
CD81/AKT/actin may exist and function in neuronal-like cell motility. Activated AKT at the 272 
leading edge of the cell is already known to participate in the regulation of cell polarity and in 273 
the reorganization of the cytoskeleton, mediating contraction of the cellular body that 274 
facilitates directed cell migration (Xue et al. 2013). AKT is one of the best-known targets of 275 
PI3K, and the PI3K/AKT pathway has role in neural migration by e.g. enhancing the 276 
secretion of matrix metalloproteinase (MMP)-2 and MMP-9 (Koh et al. 2015). In chicken 277 
embryo fibroblast (CEF) cells, the expression of active PI3K forms alone is enough to induce 278 
the remodelling of actin filaments towards the formation of cell’s motility structures (Qian et 279 
al 2004). The authors further reported that either the inhibition of PI3K activity with 280 
LY294002, or the disruption of AKT activity in CEF cells inhibited both actin remodelling 281 
and PI3K-induced cell migration (Qian et al. 2004). In our work, further support to the 282 
existence of a CD81/AKT/actin tri-complex active in cell motility comes from our PI3K 283 
pharmacological inhibitor data. The blocking of this signalling pathway, and thus of AKT 284 
activation, partially impaired the CD81 positive effect on cell motile phenotype. Further, 285 
PI3K inhibition leads to altered CD81 and actin subcellular distribution in the transfected SH-286 
SY5Y neuroblastoma population (Figures 3 and 4). This population comprises two types of 287 
cells: the larger S-type cells that are more neuroepithelial-related, and the smaller more 288 
neuronal-related N-type cells (da Rocha et al. 2015). In all CD81 overexpressing cells there 289 
was a decrease in F-actin stress fibres. Moreover, CD81 overexpressing larger cells 290 
(potentially S-type) presented and intracellular accumulation of CD81/F-actin into 291 
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perinuclear ring-like structures, cytoplasmic agglomerates and/or protruding filaments. Other 292 
authors have reported that CD81 overexpression promoted the formation of microvilli in B-293 
cells, via reorganization of the cortical actin cytoskeleton (Bari et al. 2011). Further, CD81 294 
overexpressing smaller (potential N-type) cells increased their neuronal-like differentiated 295 
phenotype.   296 
The fact that F-actin co-localizes with several of the CD81 intracellular agglomerates agrees 297 
with the hypothesis that CD81-actin interaction is part of the mechanism by which CD81 298 
regulates cell migration. Since impairing AKT activation resulted both in CD81 and actin re-299 
location and in decreased CD81-induced motile phenotype (Figures 3 and 4), and since AKT 300 
is known to bind CD81 and to phosphorylate actin to promote it’s remodelling, the 301 
hypothesis that a complex of active AKT-CD81-actin exists is very reasonable, and would 302 
partially explain the role of CD81 in cell migration. We hypothesize that if such a complex 303 
exists it is necessary for, at least, actin polymerization and the polarized distribution of F-304 
actin into motile structures such as stress fibres and adhesion sites.  305 
In addition to AKT, the molecular mechanism by which CD81 promotes neuronal-like cells 306 
motility may also involve other CD81 interactors and actin regulator such as Rac. This small 307 
G protein of the Rho family is known to promote actin polymerization and to be involved in 308 
cell migration. Rac may act downstream CD81, since a direct association between CD81 and 309 
Rac in TEM was reported, with CD81-Rac complexes being most prominent at motile cells’ 310 
leading edge (Tejera et al. 2013). These authors hypothesize that CD81 regulates Rac1 311 
dynamics and localization at the cell membrane during membrane protrusion and during the 312 
formation of adhesion complexes (Tejera et al. 2013). Noteworthy, besides activating AKT, 313 
PI3K can also activate Rac, and both molecules can be involved in PI3K-induced cell motile 314 
phenotype (Qian et al. 2004). Other authors have already hypothesized that CD81 may 315 
coordinate cell migration via the regulation of key migration-related proteins with which 316 
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CD81 interacts in the ‘tetraspanin web’(Boucheix & Rubinstein 2001; Hemler 2005; Jiang et 317 
al. 2015). Since Rac, AKT and actin are CD81-binding proteins, and CD81 is involved in 318 
tetraspanin microdomains that may ‘catalyse’ cellular processes, we propose a working 319 
scenario where, in TEM, CD81 serves as an anchor for proteins such as AKT, Rac and actin, 320 
to promote their interaction and the actin cytoskeleton remodelling that will lead to the 321 
acquisition of the polarized cell motile morphology. Although the SH-SY5Y cell line has 322 
been extensively used in the study of neuronal cell cultures, it is tumour-derived and cannot 323 
fully recapitulate the properties of the neuronal cells in vivo (Gordon et al. 2013). Thus our 324 
data should be validated using primary neuronal cells or human induced pluripotent stem cell 325 
(iPSC)-derived neurons. The confirmation of our hypothesis will improve our knowledge of 326 
the molecular mechanisms behind neuronal cell migration, an important event underlying 327 
various major neurological processes, such as neural development and neuroregeneration. 328 
 329 
Conclusion 330 
In neuronal-like cells, similarly to its role in immune cells, CD81 promotes cell 331 
transformation events that underlie the acquisition of a migratory phenotype. The mechanism 332 
behind CD81-enhancement of SH-SY5Y motility passes by the remodelling of the actin 333 
cytoskeleton. Moreover, our findings indicate that the PI3K-AKT signalling mediates this 334 
CD81 role in actin remodelling and subsequent polarization into a motile cell, and support the 335 
existence of a CD81-AKT-actin complex as a key molecular effector of this CD81 role.  336 
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Figures Captions 411 
 412 
Figure 1. CD81 transfected neuronal-like cells have increased migratory phenotype. A. 413 
and B. Confocal micrographs of SH-SY5Y neuroblastoma cells non-transfected (A.) or 414 
transfected (B.) with CD81 for 24h. Cells were fixed and subjected to ICC with an anti-CD81 415 
antibody (labeled with AlexaFluor488, in green), red AlexaFluor568 Phalloidin to stain F-416 
actin, and DAPI to stain the cells’ nuclei (in blue). Dashed rectangle in B. images – cell 417 
leading edge. Full arrows – stress fibres. Open arrows – filopodia and similar cell protrusions. 418 
Asterisks – potential focal adhesion sites. Endg, endogenous; Trf, transfected. C. Graphic 419 
representation of the percentages of cells with a migratory phenotype, visually scored in SH-420 
SY5Y cells overexpressing or not CD81. *, p < 0.05, statistical significance determined by 421 
either the independent sample t-test or the Mann-Whitney U test (p = 0.012 in both); n=5. 422 
 423 
Figure 2. Co-localization between CD81 and AKT1. Confocal microscopy analysis of the 424 
subcellular co-localization of CD81 (in green), either exogenous (A., transfected cells) or 425 
endogenous (B., parental cells), with AKT1 (in red). ICC was performed using an anti-CD81 426 
antibody (green, secondary antibody AlexaFluor488) and anti-AKT1 antibody (red, 427 
secondary AlexaFluor594). Open arrows – filopodia and similar cell protrusions. Full arrows 428 
– location at the cell membrane.  429 
   430 
Figure 3. PI3K inhibition decreases the percentage of migrating cells. A. SH-SY5Y cells 431 
transfected with CD81 cDNA were incubated with 10 μM LY294002, a PI3K inhibitor for 432 
18h. The effect of PI3K inhibition on the number of CD81-transfected cells with migratory 433 
phenotype was quantified, taking the number of CD81-transfected migratory cells in control 434 
22 
 
(untreated) cells as 100%. *, p < 0.05, statistical significance according to the one sample t-435 
test; p = 0.0504 when using the non-parametric Wilcoxon test; n=3. B. Confocal microscopy 436 
images of transfected CD81 and F-actin staining, in control cells (untreated; upper panel) and 437 
in cells incubated with the LY294002 PI3K inhibitor (lower panel). Full arrows indicate F-438 
actin stress fibres. Arrowheads indicate a decrease in stress fibres in LY294002 treated cells. 439 
Open arrow indicates cell with a CD81 ‘ring-like’ distribution.  440 
  441 
Figure 4. PI3K inhibition alters CD81 and F-actin subcellular distribution. CD81-442 
transfected SH-SY5Y cells were incubated with 10 μM of the PI3K inhibitor LY294002, for 443 
18h. Confocal microphotographs at the plasma membrane (A.) and nuclear (B.) focal planes 444 
show the abnormal concentration of CD81 internally, at cytoplasmic agglomerates and 445 
internal filaments, besides filopodia. CD81 and F-actin co-localize extensively in these 446 
structures (zoom-ins). Full arrows indicate F-actin stress fibres in non-transfected cells. 447 
Arrowheads indicate a decrease in stress fibres in transfected cells. Open arrows indicate the 448 
CD81 ‘ring-like’ distribution.  449 
Figure	   1.	   CD81	   transfected	   neuronal-­‐like	   cells	   have	  
increased	   migratory	   phenotype.	   A.	   and	   B.	   Confocal	  
micrographs	   of	   SH-­‐SY5Y	   neuroblastoma	   cells	   non-­‐
transfected	  (A.)	  or	  transfected	  (B.)	  with	  CD81	  for	  24h.	  Cells	  
were	  ﬁxed	  and	  subjected	  to	  ICC	  with	  an	  anG-­‐CD81	  anGbody	  
(labeled	   with	   AlexaFluor488,	   in	   green),	   red	   AlexaFluor568	  
Phalloidin	  to	  stain	  F-­‐acGn,	  and	  DAPI	  to	  stain	  the	  cells’	  nuclei	  
(in	  blue).	  Dashed	  rectangle	  in	  B.	  images	  –	  cell	  leading	  edge.	  
Full	   arrows	   –	   stress	   ﬁbres.	   Open	   arrows	   –	   ﬁlopodia	   and	  
similar	  cell	  protrusions.	  Asterisks	  –	  potenGal	  focal	  adhesion	  
sites.	   Endg,	   endogenous;	   Trf,	   transfected.	   C.	   Graphic	  
representaGon	  of	  the	  percentages	  of	  cells	  with	  a	  migratory	  
phenotype,	   visually	   scored	   in	   SH-­‐SY5Y	   cells	   overexpressing	  
or	  not	  CD81.	  *,	  p	  <	  0.05,	  staGsGcal	  signiﬁcance	  determined	  
by	   either	   the	   independent	   sample	   t-­‐test	   or	   the	   Mann-­‐
Whitney	  U	  test	  (p	  =	  0.012	  in	  both);	  n=5.	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Figure	  2.	  Co-­‐localiza@on	  between	  CD81	  and	  AKT1.	  Confocal	  microscopy	  analysis	  of	  the	  subcellular	  co-­‐localizaGon	  of	  
CD81	  (in	  green),	  either	  exogenous	  (A.,	  transfected	  cells)	  or	  endogenous	  (B.,	  parental	  cells),	  with	  AKT1	  (in	  red).	  ICC	  
was	   performed	   using	   an	   anG-­‐CD81	   anGbody	   (green,	   secondary	   anGbody	   AlexaFluor488)	   and	   anG-­‐AKT1	   anGbody	  
(red,	  secondary	  AlexaFluor594).	  Open	  arrows	  –	  ﬁlopodia	  and	  similar	  cell	  protrusions.	  Full	  arrows	  –	   locaGon	  at	  the	  
cell	  membrane.	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Figure	   3.	   PI3K	   inhibi@on	   decreases	   the	   percentage	   of	  migra@ng	   cells.	   A.	   SH-­‐SY5Y	   cells	   transfected	  with	  
CD81	  were	   incubated	  with	  10	  μM	  LY294002,	  a	  PI3K	   inhibitor,	   for	  18h.	  The	  eﬀect	  of	  PI3K	   inhibiGon	  on	  the	  
number	  of	   CD81-­‐transfected	   cells	  with	  migratory	  phenotype	  was	  quanGﬁed,	   taking	   the	  number	  of	   CD81-­‐
transfected	  migratory	  cells	  in	  control	  (untreated)	  cells	  as	  100%.	  *,	  p	  <	  0.05,	  staGsGcal	  signiﬁcance	  according	  
to	   the	   one	   sample	   t-­‐test;	   p	   =	   0.0504	   when	   using	   the	   non-­‐parametric	   Wilcoxon	   test;	   n=3.	   B.	   Confocal	  
microscopy	  images	  of	  transfected	  CD81	  and	  F-­‐acGn	  staining,	  in	  control	  cells	  (untreated;	  upper	  panel)	  and	  in	  
cells	   incubated	  with	   the	   LY294002	   PI3K	   inhibitor	   (lower	   panel).	   Full	   arrows	   indicate	   F-­‐acGn	   stress	   ﬁbres.	  
Arrowheads	  indicate	  a	  decrease	  in	  stress	  ﬁbres	  in	  LY294002	  treated	  cells.	  Open	  arrow	  indicates	  cell	  with	  a	  
CD81	  ‘ring-­‐like’	  distribuGon.	  	  
A.                B. F-­‐ac@n	  Trf	  CD81	   Merge	  
Untreated	  
PI3K	  inhibitor	  
0 
20 
40 
60 
80 
100 
120 
Control LY294002 
%
 o
f m
ig
ra
to
ry
 c
el
ls
 
Effect of PI3K inhibition on 
the migratory phenotype 
*	  
20 µm 
Figure	  4.	  PI3K	  inhibi@on	  alters	  CD81	  and	  F-­‐ac@n	  subcellular	  distribu@on.	  CD81-­‐transfected	  SH-­‐SY5Y	  
cells	  were	  incubated	  with	  10	  μM	  of	  the	  PI3K	  inhibitor	  LY294002,	  for	  18h.	  Confocal	  microphotographs	  
at	   the	   plasma	  membrane	   (A.)	   and	   nuclear	   (B.)	   focal	   planes	   show	   the	   abnormal	   concentraGon	   of	  
CD81	  internally,	  at	  cytoplasmic	  agglomerates	  and	  internal	  ﬁlaments,	  besides	  ﬁlopodia.	  CD81	  and	  F-­‐
acGn	  co-­‐localize	  extensively	  in	  these	  structures	  (zoom-­‐ins).	  Full	  arrows	  indicate	  F-­‐acGn	  stress	  ﬁbres	  in	  
non-­‐transfected	   cells.	   Arrowheads	   indicate	   a	   decrease	   in	   stress	   ﬁbres	   in	   transfected	   cells.	   Open	  
arrows	  indicate	  the	  CD81	  ‘ring-­‐like’	  distribuGon.	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